Skip to main content

Table 2 Correlation between MΦ subsets and SF sCD163 and sCD14

From: Synovial fluid monocyte/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: a cohort study

  sCD163 (ng/ml) sCD14 (ug/ml)
Pearson’s r, CI Adjusted p Pearson’s r, CI Adjusted p
CD14+CD16+-MΦs/total SF MΦs −0.007 (− 0.263, 0.232) 1.000 −0.044 (− 0.306, 0.226) 0.996
CD14+CD16neg-MΦs /total SF MΦs 0.009 (− 0.231, 0.250) 1.000 0.073 (− 0.185, 0.318) 0.967
CD14lowCD16+-MΦs /total SF MΦs − 0.008 (− 0.186, 0.270) 1.000 −0.110 (− 0.300, 0.091) 0.708
Total MΦs/total SFLs − 0.147 (− 0.334, 0.074) 0.695 −0.304 (− 0.491, − 0.073) 0.028
CD14+CD16+-MΦs/total SFLs −0.131 (− 0.329, 0.097) 0.654 −0.294 (− 0.482, − 0.054) 0.043
CD14+CD16neg-MΦs/total SFLs −0.134 (− 0.328, 0.090) 0.614 −0.225 (− 0.428, 0.000) 0.165
CD14lowCD16+-MΦs/total SFLs − 0.053 (− 0.218, 0.226) 0.969 −0.223 (− 0.390, − 0.018) 0.111
  1. N = 81. Values in boldface show results with significant effect estimates (β)
  2. monocytes/macrophages, SF synovial fluid, SFL, synovial fluid leukocytes